Bismuth Quadruple Therapy for H. pylori
For treatment-naive H. pylori infection, use bismuth quadruple therapy for 14 days: PPI (standard dose twice daily), bismuth subsalicylate 262 mg (2 tablets) four times daily, tetracycline 500 mg four times daily, and metronidazole 500 mg four times daily. 1, 2
Recommended Regimen Components
The standard bismuth quadruple therapy consists of:
- PPI: Standard dose twice daily (esomeprazole 20 mg, rabeprazole 20 mg, omeprazole 20 mg, lansoprazole 30 mg, or pantoprazole 40 mg). Higher-potency PPIs like esomeprazole or rabeprazole 20-40 mg twice daily are preferred when available 1
- Bismuth: 262 mg bismuth subsalicylate (2 tablets) four times daily, or colloidal bismuth subcitrate 120 mg (1 tablet) four times daily 2
- Tetracycline: 500 mg four times daily 1, 2
- Metronidazole: 500 mg four times daily (or 400 mg four times daily) 2
Timing of Administration
Optimal dosing schedule: bismuth 30 minutes before meals, tetracycline and metronidazole 30 minutes after meals, and PPI 30 minutes before meals and at bedtime 1
Treatment Duration: 14 Days vs 10 Days
The Toronto Consensus, Maastricht V/Florence, and ACG guidelines all recommend 14 days as the preferred duration for first-line therapy 2. The Toronto Consensus specifically emphasizes 14 days based on evidence of superiority over shorter durations, while Maastricht V/Florence allows 10 days only if proven locally effective 2.
Recent evidence shows 10-day regimens may achieve comparable eradication rates (93.22% vs 93.74%) with lower adverse effects (22.59% vs 28.50%) 3, but the guideline consensus favors 14 days to maximize first-attempt success and avoid retreatment 2.
Why Bismuth Quadruple Therapy is Preferred
Bismuth quadruple therapy is the only regimen that can be given empirically in most areas due to rising antibiotic resistance 1. Key advantages include:
- Maintains high efficacy even with metronidazole-resistant strains when given at adequate dose and duration 2, 4
- Effective in areas with high dual resistance to clarithromycin and metronidazole 2
- Tetracycline and amoxicillin resistance remain rare 2
- Achieves >90% eradication rates when optimized 1, 5
Clinical Context and Positioning
First-Line Therapy
All three major guidelines (Toronto, Maastricht V/Florence, ACG) recommend bismuth quadruple therapy as first-line treatment, particularly in regions where clarithromycin resistance exceeds 15% 2. This applies to most areas globally given rising resistance patterns 1.
Rescue Therapy
After failure of clarithromycin-based or levofloxacin-based regimens, bismuth quadruple therapy is the most reliable rescue option 2. All three guideline groups unanimously recommend it as a rescue choice 2.
Penicillin Allergy
Bismuth quadruple therapy is the treatment of choice for patients with true penicillin allergy 2.
Important Caveats and Practical Considerations
Tetracycline Availability and Substitution
Do not substitute doxycycline for tetracycline—results are significantly inferior 1. If tetracycline is unavailable, minocycline may serve as an alternative, though evidence is limited 6. Generic tetracycline costs approximately $660 retail in the US but can be obtained for under $100 with discount coupons 1.
Formulation Options
The combination product Pylera® is packaged for 10-day therapy and costs >$1,000 in the US (versus ~€70 in Europe) 1. Individual generic components prescribed separately offer a more cost-effective alternative 1.
Metronidazole Resistance
Unlike clarithromycin or levofloxacin resistance, metronidazole resistance can be partially or completely overcome by increasing dose and duration when combined with bismuth 4. The synergistic effect of bismuth allows metronidazole to be re-used even after previous exposure 2.
Adverse Effects
The regimen is generally well tolerated with mostly mild, transient gastrointestinal adverse events including nausea, epigastric soreness, loose stool, and taste perversion 6, 7. Compliance rates are typically high (96-100%) 3, 7.
Contraindications and Special Populations
Avoid in patients with:
- Bismuth hypersensitivity
- Tetracycline allergy (consider alternative antibiotics with susceptibility testing)
- Pregnancy (tetracyclines are contraindicated)
- Children under 8 years (tetracycline affects bone/tooth development)
- Severe renal impairment (adjust metronidazole dosing)
Key Pitfall to Avoid
The most critical error is using shorter durations (7 days) or suboptimal dosing that fails to achieve >90% eradication rates 1, 4. This leads to retreatment, increased resistance, and negative impacts on gut microbiota 2. Always prioritize succeeding on the first attempt by using the full 14-day optimized regimen 2.